For chronic dialysis patients, a unique population requiring continuous medical care, methodologies to monitor patient outcomes, such as hospitalizations, over time, after initiation of dialysis, are of particular interest. Contributing to patient hospitalizations is a number of multilevel covariates such as demographics and comorbidities at the patient level and staffing composition at the dialysis facility level. We propose a varying coefficient model for multilevel risk factors (VCM-MR) to study the time-varying effects of covariates on patient hospitalization risk as a function of time on dialysis. The proposed VCM-MR also includes subject-specific random effects to account for within-subject correlation and dialysis facility-specific f...
Competing risks are omnipresent in administrative records and disease registries. The increasing ava...
Medicare claims data are commonly used to query comorbidities for case-mix adjustment in research of...
Mixed types of multivariate outcomes are common in clinical investigations. Survival time is one of ...
For chronic dialysis patients, a unique population requiring continuous medical care, methodologies ...
For chronic dialysis patients, a unique population requiring continuous medical care, hospitalizatio...
For patients on dialysis, hospitalizations remain a major risk factor for mortality and morbidity. W...
Over 785,000 individuals in the U.S. have end-stage renal disease (ESRD) with about 70% of patients ...
More than 720,000 patients with end-stage renal disease in the United States require life-sustaining...
In the first chapter of this work, we characterize the dynamics of cardiovascular event risk traject...
Among patients on dialysis, cardiovascular disease and infection are leading causes of hospitalizati...
Motivated by the United States Renal Data System (USRDS), we propose a joint modeling framework for ...
End-stage renal disease patients on dialysis experience frequent hospitalizations. In addition to kn...
Standard profiling analysis aims to evaluate medical providers, such as hospitals, nursing homes, or...
Profiling analysis aims to evaluate health care providers, such as hospitals, nursing homes, or dial...
Background and objectives. In chronic hemodialysis (HD), patients' hospitalizations result in signif...
Competing risks are omnipresent in administrative records and disease registries. The increasing ava...
Medicare claims data are commonly used to query comorbidities for case-mix adjustment in research of...
Mixed types of multivariate outcomes are common in clinical investigations. Survival time is one of ...
For chronic dialysis patients, a unique population requiring continuous medical care, methodologies ...
For chronic dialysis patients, a unique population requiring continuous medical care, hospitalizatio...
For patients on dialysis, hospitalizations remain a major risk factor for mortality and morbidity. W...
Over 785,000 individuals in the U.S. have end-stage renal disease (ESRD) with about 70% of patients ...
More than 720,000 patients with end-stage renal disease in the United States require life-sustaining...
In the first chapter of this work, we characterize the dynamics of cardiovascular event risk traject...
Among patients on dialysis, cardiovascular disease and infection are leading causes of hospitalizati...
Motivated by the United States Renal Data System (USRDS), we propose a joint modeling framework for ...
End-stage renal disease patients on dialysis experience frequent hospitalizations. In addition to kn...
Standard profiling analysis aims to evaluate medical providers, such as hospitals, nursing homes, or...
Profiling analysis aims to evaluate health care providers, such as hospitals, nursing homes, or dial...
Background and objectives. In chronic hemodialysis (HD), patients' hospitalizations result in signif...
Competing risks are omnipresent in administrative records and disease registries. The increasing ava...
Medicare claims data are commonly used to query comorbidities for case-mix adjustment in research of...
Mixed types of multivariate outcomes are common in clinical investigations. Survival time is one of ...